Kaplan–Meier survival analysis was used to calculate the SPON2 expression level, differentiation, and positive lymph node metastasis to correlate these with patient survival time (Figure 3). This evidence concerns the gene SPON2 and metastatic malignant neoplasm in the lymph nodes.